EMR
74
3
PCAR
58
2
AVY
57
6
UA
65
15
WFC
82
3
RL
78
6
AMP
67
-3
ISRG
71
-3
SRE
54
-12
AN
61
3
MHK
55
6
CMA
61
3
AES
43
2
WAT
57
2
EXR
64
4
HPE
50
-13
FSLR
49
-5
TRIP
50
3
CRM
65
-2
SE
63
2
EMR
74
3
PCAR
58
2
AVY
57
6
UA
65
15
WFC
82
3
RL
78
6
AMP
67
-3
ISRG
71
-3
SRE
54
-12
AN
61
3
MHK
55
6
CMA
61
3
AES
43
2
WAT
57
2
EXR
64
4
HPE
50
-13
FSLR
49
-5
TRIP
50
3
CRM
65
-2
SE
63
2
Financhill
Back

Akebia Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
66

AKBA
Akebia Therapeutics

Last Price:
2.05
Seasonality Move:
46.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Akebia Therapeutics Price Quote

$2.05
+0.12 (+6.22%)
(Updated: November 26, 2024 at 5:55 PM ET)

Akebia Therapeutics Key Stats

Buy
66
Akebia Therapeutics (AKBA) is a Buy
Day range:
$1.88 - $1.97
52-week range:
$0.80 - $2.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.31
P/B ratio:
0%
Volume:
2.5M
Avg. volume:
2.3M
1-year change:
93%
Market cap:
$421.1M
Revenue:
$194.6M
EPS:
$-0.23

How Much Does Akebia Therapeutics Make?

Is Akebia Therapeutics Growing As A Company?

  • What Is Akebia Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.11%
  • What Is Akebia Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Akebia Therapeutics Stock Price Performance

What Is Akebia Therapeutics 52-Week High & Low?

Akebia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akebia Therapeutics?

Is Akebia Therapeutics Cash Flow Positive?

  • What Is AKBA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$38.5M
  • What Is Akebia Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $26M
  • What Is Akebia Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$31K

Akebia Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    AKBA return on invested capital is -9553.8%
  • What Is Akebia Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -20.36%
  • What Is AKBA Return On Equity?
    ROE is a measure of profitability and is 0%

Akebia Therapeutics Earnings Date & Stock Price

Akebia Therapeutics Competitors

Akebia Therapeutics Dividend Yield

Akebia Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -100%
Revenue: -10.98% -15.9%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.50
Upside from Last Price: 184.97%

Major Shareholders

  • How many AKBA shares are owned by institutional investors?
    95M AKBA shares are owned by institutional investors
  • How many AKBA shares are owned by insiders?
    7.9M AKBA shares are owned by insiders